- Report
- August 2022
- 120 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- January 2022
- 120 Pages
Global
From €4334EUR$4,750USD£3,683GBP
- Report
- August 2022
- 175 Pages
Global
From €8669EUR$9,500USD£7,366GBP
- Report
- December 2020
- 60 Pages
Global
From €2966EUR$3,250USD£2,520GBP
- Report
- December 2020
- 60 Pages
Global
From €2966EUR$3,250USD£2,520GBP
- Report
- February 2024
- 180 Pages
Global
From €4534EUR$4,969USD£3,853GBP
- Report
- October 2023
- 160 Pages
Global
From €3284EUR$3,599USD£2,791GBP
- Report
- May 2023
- 140 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- April 2023
- 147 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- March 2023
- 147 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- March 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- January 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- August 2022
- 87 Pages
Global
From €4334EUR$4,750USD£3,683GBP
- Report
- December 2023
- 171 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- July 2022
- 241 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- September 2022
- 182 Pages
Africa, Middle East
From €3148EUR$3,450USD£2,675GBP
- Report
- September 2022
- 73 Pages
Europe
From €3148EUR$3,450USD£2,675GBP
- Report
- September 2022
- 195 Pages
Asia Pacific
From €3148EUR$3,450USD£2,675GBP
- Report
- September 2022
- 174 Pages
From €3148EUR$3,450USD£2,675GBP
- Report
- September 2022
- 173 Pages
North America
From €3148EUR$3,450USD£2,675GBP

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more